Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort ascending
Nov
1
2023
PFAS Consumer Fraud Lawsuit Update: New Protein Supplement Case In NY CMBG3 Law
Jun
4
2021
FDA Ban On PFAS In Food Packaging Brought To Forefront CMBG3 Law
Jun
21
2021
PFAS In Cosmetics: Financial and Insurance Companies On Notice CMBG3 Law
Jul
5
2022
Current Trends in Legislation – June 2022 CMBG3 Law
Jul
25
2022
SAB PFAS Hearing Delivered News of Wider PFAS Regulation Possibility CMBG3 Law
Jul
29
2022
NAS PFAS Report Will Influence Lawsuit Trends CMBG3 Law
Oct
22
2021
ESG and Emerging Contaminants – Investors Beware CMBG3 Law
Oct
7
2020
October 2020 Talc Lawsuit Update: Johnson & Johnson Agrees to Pay $100 Million Settlement Console and Associates, P.C.
Jun
8
2020
Are Qualified Patients Unqualified Parents? University of Missouri School of Law
May
12
2020
Patentability of COVID-19 Biotech, Pharma & Personal Protective Equipment Inventions Global IP Counselors
May
13
2020
Patentability of COVID-19 Software Inventions: Artificial Intelligence (AI), Data Storage & Blockchain Global IP Counselors
Sep
11
2020
California Supreme Court Clarifies Bounds of Legitimate Competition Under Tort and Antitrust Law The National Law Review's Guest Contributors
May
27
2022
Legal Protections for Food Safety Whistleblowers Katz Banks Kumin LLP
Jul
9
2020
Former JUUL Employee Seeks Injunction Against Pre-Employment NDA Katz Banks Kumin LLP
Mar
29
2020
Whistleblower Suit Against Pharmaceutical Company Heads to Trial Katz Banks Kumin LLP
Nov
17
2021
Intellectual Property Consolidation in the Agriculture Industry Summa PLLC
Mar
24
2020
The Global Patent Race for a COVID-19 Vaccine Summa PLLC
Nov
11
2020
Rage Against the Vaccine: Communicating COVID-19 Facts Amid Anti-Vaxxer Outcry Hennes Communications
Apr
9
2020
United States Intervenes and Settles Qui Tam False Claims Act Case Against Compound Pharmacies for $426,000 Kohn, Kohn & Colapinto
Jan
9
2020
Teva Pharmaceuticals Settles to Pay Over $519 Million in Penalties for Violations of the Foreign Corrupt Practices Act Kohn, Kohn & Colapinto
Jan
27
2020
Medicare Fraud Uncovered by Multiple Whistleblowers Kohn, Kohn & Colapinto
Sep
11
2019
What are Consumers Claiming in Juul Lawsuits? ConsumerSafety
Mar
24
2023
Judge Approves $25M Settlement of Antitrust Action Against J&J for Allegedly Blocking Biosimilars MoginRubin
Sep
18
2019
‘Big Tuna’ Antitrust Case Among Latest to Discuss Daubert Test at Class Certification Stage. But What’s Too Rigorous? MoginRubin
Feb
28
2020
FTC, FDA Team Up Against Anticompetitive Tactics in Biological Product Industry MoginRubin
Oct
29
2020
Pharma: Consumer Groups, States Support Reviving Generic Drugs Antitrust Case Against AbbVie MoginRubin
Jan
11
2022
7th Circuit: Is Each Transmission of Biometric Data a BIPA Violation? MoginRubin
Apr
14
2022
Full Ninth Circuit Removes Unwarranted Hurdles to Class Certification in Big Tuna Antitrust Case MoginRubin
Sep
18
2019
Consumer Groups and Unions Tell FTC: AbbVie-Allergen Merger Will Deny Access to More Effective and Affordable Drugs MoginRubin
Oct
29
2020
Healthcare: Anticompetitive Tying Class Action Moves Forward Against Sutter Health MoginRubin
Feb
5
2020
Agencies’ Antitrust Suit Against Drug Maker Underscores Challenges of Bringing Biosimilars to Market MoginRubin
Nov
5
2019
Billion-Dollar Merger of DNA Sequencing Firms Opposed by U.K., Questioned in U.S. MoginRubin
Jul
1
2020
Class of End-Payors Certified in Illegal Monopolization Suit Against Drug Maker Allergan MoginRubin
Nov
20
2019
Anheuser-Busch InBev, Craft Brew Alliance Take Relationship to the Next Level MoginRubin
May
19
2020
End of an Era: The U.S. is No Longer the Authority Figure for Multinational Mergers MoginRubin
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins